Equities research analysts forecast that Quorum Health Corp (NYSE:QHC) will report ($0.19) earnings per share for the current fiscal quarter, Zacks reports. Zero analysts have provided estimates for Quorum Health’s earnings. Quorum Health posted earnings of ($0.58) per share during the same quarter last year, which indicates a positive year-over-year growth rate of 67.2%. The firm is scheduled to report its next quarterly earnings results on Wednesday, November 14th.
On average, analysts expect that Quorum Health will report full-year earnings of ($1.49) per share for the current fiscal year. For the next year, analysts forecast that the firm will report earnings of ($0.97) per share. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research analysts that cover Quorum Health.
Quorum Health (NYSE:QHC) last posted its earnings results on Wednesday, August 8th. The company reported ($0.35) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.57) by $0.22. The firm had revenue of $472.63 million during the quarter. Quorum Health had a negative net margin of 9.20% and a negative return on equity of 74.93%.
A number of research analysts have issued reports on QHC shares. Zacks Investment Research raised shares of Quorum Health from a “hold” rating to a “buy” rating and set a $5.00 target price for the company in a research note on Saturday, September 8th. ValuEngine raised shares of Quorum Health from a “hold” rating to a “buy” rating in a research note on Friday, June 15th.
Quorum Health stock traded up $0.03 during midday trading on Friday, reaching $4.05. 235,700 shares of the stock traded hands, compared to its average volume of 336,219. The company has a quick ratio of 1.40, a current ratio of 1.54 and a debt-to-equity ratio of -139.43. The firm has a market capitalization of $181.02 million, a price-to-earnings ratio of -3.12 and a beta of 0.59. Quorum Health has a fifty-two week low of $3.80 and a fifty-two week high of $10.00.
A number of institutional investors have recently bought and sold shares of QHC. Koch Industries Inc. acquired a new stake in shares of Quorum Health in the 1st quarter worth approximately $103,000. Element Capital Management LLC acquired a new stake in shares of Quorum Health in the 1st quarter worth approximately $194,000. Jane Street Group LLC lifted its stake in shares of Quorum Health by 130.5% in the 1st quarter. Jane Street Group LLC now owns 24,323 shares of the company’s stock worth $199,000 after acquiring an additional 13,771 shares during the period. Rhumbline Advisers lifted its stake in shares of Quorum Health by 103.7% in the 2nd quarter. Rhumbline Advisers now owns 51,166 shares of the company’s stock worth $256,000 after acquiring an additional 26,045 shares during the period. Finally, Schwab Charles Investment Management Inc. acquired a new stake in shares of Quorum Health in the 2nd quarter worth approximately $267,000. 96.74% of the stock is owned by hedge funds and other institutional investors.
About Quorum Health
Quorum Health Corporation provides hospital and outpatient healthcare services in the United States. Its hospital and outpatient healthcare services include general and acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetric, diagnostic, psychiatric, and rehabilitation services.
Featured Story: What are the benefits of buying treasury bonds?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Quorum Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health and related companies with MarketBeat.com's FREE daily email newsletter.